Klepierre SA (LI)
Euronext Paris · France · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 35.24 |
|---|---|
| 52-week range | 30.86 – 40.38 |
| Return, 1 month / 3 months | −3.6% / −7.5% |
| Return, 1 year / 3 years | +11.6% / +88.8% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 44 |
| Volatility (1 year) | 16.5% |
| Worst drawdown (1 year) | -13.9% |
| Average daily value traded | 19.42M EUR |
| Dividend yield | 5.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Klépierre is a real estate company based in Paris that owns and manages shopping centres, mainly in continental Europe. Its properties are large retail destinations that bring together shops, restaurants and leisure space, and the company works with retailers as tenants while managing and developing these sites. It also runs shopping centres under its own brand names in several European countries, serving local shoppers and the communities around its centres.
The shares are listed on the Euronext Paris in France under the code LI, and the price on this page is in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Klepierre SA (LI) trades on the Euronext Paris in France. It last closed at EUR 35.24 on 22 October 2026.
Its price-based Market X-Ray is 81 out of 100 (a strong price profile), ranking 22 of 625 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 11.6% and over the last three months it fell 7.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Paris
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.7% | ||
| From 52-week high | -11.9% | ||
| Momentum | 68 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -7.5% | ||
| 6-month return | 3.1% | ||
| 12-month return, skipping the last month | 15.7% | ||
| Stability (higher is calmer) | 93 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -13.9% | ||
| Liquidity | 93 · Strong | Trades actively. | |
| Average daily value traded | 19.42M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 66 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.4% | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −3.6% |
| 3 months | −7.5% |
| 6 months | +3.1% |
| 1 year | +11.6% |
| 3 years | +88.8% |
| 5 years | +134.0% |
Signals
| 50-day / 200-day average | 36.65 / 34.64 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.59 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Jul 2026 | EUR 0.9500 |
| 6 Mar 2026 | EUR 0.9500 |
| 8 Jul 2025 | EUR 0.9250 |
| 4 Mar 2025 | EUR 0.9250 |
| 9 Jul 2024 | EUR 0.1017 |
| 22 Mar 2024 | EUR 0.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Paris; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.